The surge of HBsAb level in a HBsAg-negative ES-SCLC patient after anlotinib plus atezolizumab treatment: A case report

Chen, GJ; Tian, T; Cai, XD

Cai, XD (通讯作者),Jinan Univ, Affiliated Hosp 1, Dept Resp, Guangzhou, Peoples R China.

FRONTIERS IN ONCOLOGY, 2023; 13 ():

Abstract

Small-cell lung cancer (SCLC) is a poorly differentiated neuroendocrine tumor with endocrine function. For decades, chemotherapy and immune checkpoint......

Full Text Link